CN Patent

CN104945385A — Tipracil盐酸盐的新晶型及其制备方法

Assigned to Jiangsu Hansoh Pharmaceutical Group Co Ltd · Expires 2015-09-30 · 11y expired

What this patent protects

本发明公开了Tipracil盐酸盐的新晶型及其制备方法。具体地，本发明涉及式(1)所示Tipiracil盐酸盐即5-氯-6-[(2-亚氨基-1-吡咯烷)甲基]-2,4(1H,3H)-嘧啶二酮盐酸盐的晶型及其制备方法。该晶型稳定易得，适合药物制剂的应用需求。

USPTO Abstract

本发明公开了Tipracil盐酸盐的新晶型及其制备方法。具体地，本发明涉及式(1)所示Tipiracil盐酸盐即5-氯-6-[(2-亚氨基-1-吡咯烷)甲基]-2,4(1H,3H)-嘧啶二酮盐酸盐的晶型及其制备方法。该晶型稳定易得，适合药物制剂的应用需求。

Drugs covered by this patent

Patent Metadata

Patent number: CN104945385A
Jurisdiction: CN
Classification: —
Expires: 2015-09-30
Drug substance claim: No
Drug product claim: No
Assignee: Jiangsu Hansoh Pharmaceutical Group Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.